Younger age at initiation of subcutaneous treprostinil is associated with better response in pediatric Group 1 pulmonary arterial hypertension

Ähnliche Einträge

• Treprostinil Is Associated With Early and Sustained Improvement in Group 3 Pulmonary Hypertension and Right Ventricular Function in Children
  von: Kaushik Parvathaneni, et al.
  Veröffentlicht: (2026)
• Importance of age at diagnosis of pulmonary hypertension in children living at high altitude: Longitudinal follow‐up of 86 patients
  von: Gabriel F. Diaz, et al.
  Veröffentlicht: (2025)
• Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States
  von: Harrison W. Farber, et al.
  Veröffentlicht: (2024)
• Impact of general anesthesia on the echocardiographic assessment of right ventricular function in pediatric patients with pulmonary arterial hypertension
  von: Charles T. Simpkin, et al.
  Veröffentlicht: (2024)
• Barriers to and facilitators of physical activity in pediatric pulmonary hypertension
  von: Catherine M. Avitabile, et al.
  Veröffentlicht: (2024)